RT Journal
A1 Wilson LE, Blythe D, Sharfstein JM
T1 Fungal meningitis from injection of contaminated steroids: A compounding problem
JF JAMA
JO JAMA
YR 2012
FD December 19
VO 308
IS 23
SP 2461
OP 2462
DO 10.1001/jama.2012.47932
UL http://dx.doi.org/10.1001/jama.2012.47932
AB 
The year is 2002. According to the San Francisco Chronicle, “the case of Doc's Pharmacy illustrates how doctors, as well as their patients, are unaware of the risks inherent in pharmacy compounding.”1 Not long after, the Kansas City Star reviews a series of compounding-related injuries and deaths from across the country. A pharmaceutical industry executive is quoted by the paper as saying, “It is just a matter of time before somebody makes a grossly contaminated product and scores of people die. . . . People will then be asking, ‘Why did this happen?’”2